NO20021867D0 - Liposomformulering av 6,9-bis-[(2-aminoetyl)- amino]benzo[g]isokinolin-5,10-dion-dimaleat - Google Patents

Liposomformulering av 6,9-bis-[(2-aminoetyl)- amino]benzo[g]isokinolin-5,10-dion-dimaleat

Info

Publication number
NO20021867D0
NO20021867D0 NO20021867A NO20021867A NO20021867D0 NO 20021867 D0 NO20021867 D0 NO 20021867D0 NO 20021867 A NO20021867 A NO 20021867A NO 20021867 A NO20021867 A NO 20021867A NO 20021867 D0 NO20021867 D0 NO 20021867D0
Authority
NO
Norway
Prior art keywords
isoquinoline
aminoethyl
benzo
bis
amino
Prior art date
Application number
NO20021867A
Other languages
English (en)
Other versions
NO20021867L (no
Inventor
Carlo Bugatti
Original Assignee
Novuspharma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novuspharma Spa filed Critical Novuspharma Spa
Publication of NO20021867L publication Critical patent/NO20021867L/no
Publication of NO20021867D0 publication Critical patent/NO20021867D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20021867A 1999-10-22 2002-04-19 Liposomformulering av 6,9-bis-[(2-aminoetyl)- amino]benzo[g]isokinolin-5,10-dion-dimaleat NO20021867D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999MI002219A IT1315253B1 (it) 1999-10-22 1999-10-22 Preparazione liposomiale di 6,9-bis-(2-amminoetil)ammino|benzog|isochinolin-5,10-dione dimaleato
PCT/EP2000/010303 WO2001028521A2 (en) 1999-10-22 2000-10-19 Liposome formulation of 6,9-bis-[(2-aminoethyl)-amino]benzo[g]isoquinoline-5,10-dione dimaleate

Publications (2)

Publication Number Publication Date
NO20021867L NO20021867L (no) 2002-04-19
NO20021867D0 true NO20021867D0 (no) 2002-04-19

Family

ID=11383836

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021867A NO20021867D0 (no) 1999-10-22 2002-04-19 Liposomformulering av 6,9-bis-[(2-aminoetyl)- amino]benzo[g]isokinolin-5,10-dion-dimaleat

Country Status (23)

Country Link
US (1) US7449197B2 (no)
EP (1) EP1221940B1 (no)
JP (1) JP2003512313A (no)
KR (1) KR20020063880A (no)
CN (1) CN1164261C (no)
AT (1) ATE335468T1 (no)
AU (1) AU772339B2 (no)
BR (1) BR0014881A (no)
CA (1) CA2386143A1 (no)
CZ (1) CZ20021388A3 (no)
DE (1) DE60029979T2 (no)
EA (1) EA004477B1 (no)
ES (1) ES2269200T3 (no)
HU (1) HUP0203473A3 (no)
IL (2) IL149212A0 (no)
IT (1) IT1315253B1 (no)
MX (1) MXPA02003939A (no)
NO (1) NO20021867D0 (no)
NZ (1) NZ518005A (no)
PL (1) PL197412B1 (no)
SK (1) SK284247B6 (no)
WO (1) WO2001028521A2 (no)
ZA (1) ZA200203128B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2353593A1 (en) * 1998-12-18 2000-06-22 Hadasit Medical Research Services & Development Ltd. Method of administering a compound to multi-drug resistant cells
ITMI20021040A1 (it) * 2002-05-16 2003-11-17 Novuspharma Spa Composizioni farmaceutiche iniettabili di un derivato antracenedionico ad attivita' antitumorale
CN1305881C (zh) * 2004-08-13 2007-03-21 河南工业大学 磷脂酰胆碱的制备方法
CN103479578B (zh) * 2012-06-14 2016-08-03 沈阳药科大学 一种马来酸匹杉琼的脂质体制剂及其制备工艺
CN105596295B (zh) * 2016-01-25 2018-03-16 北京博恩特药业有限公司 马来酸匹杉琼脂质体及其制备方法
CN105997896B (zh) * 2016-05-28 2019-07-05 长沙秋点兵信息科技有限公司 治疗非霍奇金淋巴瘤的注射用冻干粉及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6442418A (en) * 1985-12-06 1989-02-14 Yissum Res Dev Co Liposome/anthraquinone drug composition and therapy therewith
US4797285A (en) * 1985-12-06 1989-01-10 Yissum Research And Development Company Of The Hebrew University Of Jerusalem Lipsome/anthraquinone drug composition and method
MX9203808A (es) * 1987-03-05 1992-07-01 Liposome Co Inc Formulaciones de alto contenido de medicamento: lipido, de agentes liposomicos-antineoplasticos.
US5013556A (en) * 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
ES2072223B1 (es) * 1993-11-25 1996-03-16 Lipotec Sa Liposomas encapsulando doxorubicina.
WO1995024201A1 (fr) * 1994-03-11 1995-09-14 Yoshitomi Pharmaceutical Industries, Ltd. Preparation de liposomes
US5506232A (en) * 1994-03-28 1996-04-09 Boehringer Mannheim Italia S.P.A. 6,9-bis[(2-aminoethyl)amino]benzo[g]isoquinoline-5,10-dione and its dimaleate salt
US5587382A (en) * 1994-03-28 1996-12-24 Boehringer Mannheim Italia, Spa 6,9-bis[(2-aminoethyl) amino]benzo [g]isoquinoline-5,10- dione dimaleate; an aza-anthracenedione with reduced cardiotoxicity
WO1999011242A1 (en) * 1997-09-04 1999-03-11 Biozone Laboratories, Inc. Oral liposomal delivery system

Also Published As

Publication number Publication date
CN1164261C (zh) 2004-09-01
EP1221940A2 (en) 2002-07-17
DE60029979D1 (de) 2006-09-21
HUP0203473A2 (hu) 2003-02-28
WO2001028521A2 (en) 2001-04-26
CN1382039A (zh) 2002-11-27
HUP0203473A3 (en) 2003-12-29
JP2003512313A (ja) 2003-04-02
CZ20021388A3 (cs) 2002-08-14
IT1315253B1 (it) 2003-02-03
US20060078607A1 (en) 2006-04-13
AU772339B2 (en) 2004-04-22
NO20021867L (no) 2002-04-19
MXPA02003939A (es) 2004-06-25
DE60029979T2 (de) 2007-02-22
SK284247B6 (sk) 2004-12-01
US7449197B2 (en) 2008-11-11
ITMI992219A1 (it) 2001-04-22
ATE335468T1 (de) 2006-09-15
IL149212A (en) 2006-12-10
BR0014881A (pt) 2002-06-11
ES2269200T3 (es) 2007-04-01
ZA200203128B (en) 2003-06-05
EP1221940B1 (en) 2006-08-09
PL197412B1 (pl) 2008-03-31
AU1514601A (en) 2001-04-30
SK5382002A3 (en) 2002-09-10
CA2386143A1 (en) 2001-04-26
PL354610A1 (en) 2004-02-09
WO2001028521A3 (en) 2002-04-25
NZ518005A (en) 2003-10-31
EA004477B1 (ru) 2004-04-29
EA200200389A1 (ru) 2002-08-29
KR20020063880A (ko) 2002-08-05
IL149212A0 (en) 2002-11-10

Similar Documents

Publication Publication Date Title
YU84703A (sh) Oralni rastvor aripiprazola
HUP9802221A2 (hu) Parazitaellenes hatású markfortin- és paraherkvamidszármazékok
HUP0201711A2 (en) Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as a medicament and pharmaceutical preparations containing the same
AU2002255077A1 (en) Derivatives of N-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
NO20034267L (no) Derivater av N-(arylsulfonyl)beta-aminosyrer omfattende en substituert aminometylgruppe, fremgangsmåte for fremstilling derav samtfarmasöytiske preparaterinneholdende de samme
HUP9900457A3 (en) Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
HRP20020428B1 (en) Bicyclic amino acids as pharmaceutical agents
NO991405L (no) Belagt partikkelformulering
WO1999044608A8 (en) New use
NO20006646D0 (no) Aminosyrederivater og legemidler inneholdende de samme som aktiv bestanddel
NO985145D0 (no) Farmas°ytiske preparater for forsinket frigj°ring av uoppl°selige, aktive bestanddeler
NO20021867L (no) Liposomformulering av 6,9-bis-[(2-aminoetyl)- amino]benzo[g]isokinolin-5,10-dion-dimaleat
TR200000697T2 (tr) İkame edilmiş 1,2,3,4,5,6-Heksahidro-2,6-Metano-3-Benzazosin-10-OL'ler, üretim yöntemleri ve farmasötik preparat olarak kullanımları.
BR9812085A (pt) "método para a sìntese de derivados de quinolina"
EP0842663A4 (en) OPHTHALMIC PREPARATIONS
HUP9702448A2 (hu) Indolkarbonsavat tartalmazó, parenterálisan adható gyógyászati készítmény
MX9709453A (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion.
BG106151A (en) Pharmaceutical complex
EE200300065A (et) Meetod peptiidsoolade valmistamiseks, nende peptiidsoolade kasutamine ning neid peptiidsooli sisaldavad farmatseutilised preparaadid
AP9901472A0 (en) Crystalline pharmaceutical product.
ES2131482A1 (es) Formulacion acuosa de bambuterol.
HUP0402072A3 (en) Glycine derivatives containing 1,3-oxazole or -thiazole ring and drugs containing the same as active ingredient
BR0110323A (pt) (5r) - (metilamino) - 5,6 - dihidro - 4h - imidazo [4,5,1-ij] quinolina - 2 (1h) - tiona.
AU2001274000A1 (en) Optically active 2-aminotetralin derivatives, the processes for the preparation thereof and the therapeutical use of pharmaceutical compositions containing them
AU7220898A (en) Cytotoxic compounds: derivatives of the pyrido{2,3,4-(kl)} acridine ring system

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application